Investor FAQs

Show All
Where is Ocugen's corporate headquarters?
Ocugen’s corporate headquarters are located in Malvern, PA.
Where is the company incorporated?
Ocugen is incorporated in the state of Delaware.
What is Ocugen’s fiscal year?
Ocugen operates on a fiscal year, with year-end being December 31.
How is Ocugen stock traded?
Ocugen is traded on the NASDAQ stock exchange under the symbol “OCGN”.
Who is Ocugen's transfer agent?
Ocugen’s transfer agent is Broadridge Financial Solutions, Inc. (Broadridge). You can find more information about how to contact Broadridge at: https://www.broadridge.com.
How do I report a change the address on my shareholder account?
You must send both your old and new addresses to our transfer agent, Broadridge Financial Solutions, Inc. by U.S. mail. Each stockholder in question must sign the request for an address change.
How can I replace a lost stock certificate?
Please contact our transfer agent, Broadridge Financial Solutions, Inc. at (877) 830-4936 or shareholder@broadridge.com. The company can look up your records and make any necessary adjustments. There is generally a fee involved for replacing lost certificates.
Does Ocugen have a direct stock purchase plan?
Ocugen does not offer a direct stock purchase plan.
Who is Ocugen's auditor?
Ernst & Young LLP
Who is Ocugen's legal counsel?
Pepper Hamilton LLP
Where can I get the latest corporate news releases?
You can view our recent press releases by visiting the News section of our website. If you would like to receive email alerts regarding our press releases, please visit our email alerts page.
How can I view documents Ocugen has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Ocugen’s SEC filings can be accessed under “Financials & Filings” in the “Investors” section of our corporate website or https://www.sec.gov
Whom should I contact regarding investor inquiries?
Investor inquiries should be emailed to our Vice President of Investor Relations, Kelly Beck, at kelly.beck@ocugen.com.